Measurable residual disease assessment in multiple myeloma
Saurabh Zanwar1, S Vincent Rajkumar2
1Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Leukemia
|December 5, 2025
Abstract
No abstract available in PubMed .
More Related Videos
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
7.2K
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
9.0K
